Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model.
Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model.
复制标题
作者:
Keating JJ;Runge JJ;Singhal S;Nims S;Venegas O;Durham AC;Swain G;Nie S;Low PS;Holt DE
Complete tumor resection is the most important predictor of patient survival from non-small cell lung cancer. Methods of intraoperative margin assessment following lung cancer excision are lacking. We evaluated near-infrared intraoperative imaging using a folate-targeted molecular contrast agent (OTL0038) for localization of primary lung adenocarcinoma, lymph node sampling, and margin assessment. Ten dogs with lung cancer underwent either video-assisted thoracoscopic surgery (VATS) or open thoracotomy and tumor excision following intravenous injection OTL0038. Lungs were imaged using a NIR imaging device both in vivo and ex vivo. The wound bed was re-imaged for retained fluorescence suspicious for positive tumor margins. Tumor signal-to-background ratio (SBR) was measured in all cases. Next, three human patients were enrolled in a proof-of-principle study. Tumor fluorescence was measured both in situ and ex vivo. All canine tumors fluoresced in situ (Fluoptics mean SBR 5.2 (range 2.7-8.1); Karl Storz mean SBR 2.9 (range 1.4-2.6). Additionally, fluorescence was consistent with tumor margins on pathology. Three positive lymph nodes were discovered using NIR imaging. Also, a positive retained tumor margin was discovered upon NIR imaging of the wound bed. Human pulmonary adenocarcinomas were also fluorescent both in situ and ex vivo (mean SBR > 2.0). NIR imaging identifies lung cancer in a large animal model. Additionally, NIR imaging can discriminate lymph nodes harboring cancer cells and also bring attention to a positive tumor margin. In humans, pulmonary adenocarcinomas fluoresce after injecting the targeted contrast agent.